Peer-reviewed articles

Clarke N, McDevitt J, Kearney PM, Sharp L. Increasing late stage colorectal cancer and rectal cancer mortality demonstrates the need for screening: a population based study in Ireland, 1994-2010. BMC Gastroenterology. 2014;14(1):92. doi:10.1186/1471-230X-14-92

Sharp L, Cotton S, Little J, et al. Psychosocial Impact of Alternative Management Policies for Low-Grade Cervical Abnormalities: Results from the TOMBOLA Randomised Controlled Trial. PLoS One. 2013;8(12). doi:10.1371/journal.pone.0080092

Sharp L, Carsin AE, Cantwell MM, Anderson LA, Murray LJ. Intakes of Dietary Folate and Other B Vitamins Are Associated with Risks of Esophageal Adenocarcinoma, Barrett’s Esophagus, and Reflux Esophagitis. J Nutr. 2013;143(12):1966-1973. doi:10.3945/jn.113.174664

Lansdorp-Vogelaar I, Sharp L. Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention. Best Pract Res Clin Gastroenterol. 2013;27(6):933-947. doi:10.1016/j.bpg.2013.09.005

Gurumurthy M, Cotton SC, Sharp L, et al. Postcolposcopy Management of Women With Histologically Proven CIN 1: Results From TOMBOLA. J Low Genit Tract Dis. Published online November 21, 2013. doi:10.1097/LGT.0b013e3182a1772c

Timmons A, Gooberman-Hill R, Sharp L. “It’s at a Time in Your Life When You Are Most Vulnerable”: A Qualitative Exploration of the Financial Impact of a Cancer Diagnosis and Implications for Financial Protection in Health. PLoS ONE. 2013;8(11):e77549. doi:10.1371/journal.pone.0077549

Lortet-Tieulent J, Renteria E, Sharp L, et al. Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988–2010. European Journal of Cancer. Published online November 2013. doi:10.1016/j.ejca.2013.10.014

Drummond FJ, O’Leary E, O’Neill C, Burns R, Sharp L. “Bird in the hand” cash was more effective than prize draws in increasing physician questionnaire response. Journal of Clinical Epidemiology. Published online October 31, 2013. doi:10.1016/j.jclinepi.2013.08.016

O’Brien KM, Sharp L. Trends in incidence of, and mortality from, cervical lesions in Ireland: Baseline data for future evaluation of the national cervical screening programme. Cancer Epidemiol. Published online October 12, 2013. doi:10.1016/j.canep.2013.09.002

McDevitt J, Kelly M, Comber H, Kelleher T, Dwane F, Sharp L. A population-based study of hospital length of stay and emergency readmission following surgery for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2013;44(4):e253-259. doi:10.1093/ejcts/ezt389

Drummond FJ, Barrett E, Burns R, O’Neill C, Sharp L. The number of tPSA tests continues to rise and variation in testing practices persists: a survey of laboratory services in Ireland 2008-2010. Ir J Med Sci. Published online September 27, 2013. doi:10.1007/s11845-013-1022-y

Barron TI, Cahir C, Sharp L, Bennett K. A nested case-control study of adjuvant hormonal therapy persistence and compliance, and early breast cancer recurrence in women with stage I-III breast cancer. Br J Cancer. 2013;109(6):1513-1521. doi:10.1038/bjc.2013.518

Naidoo J, Teo MY, Deady S, Comber H, Calvert P. Should Patients with Extrapulmonary Small-Cell Carcinoma Receive Prophylactic Cranial Irradiation?: Journal of Thoracic Oncology. 2013;8(9):1215-1221. doi:10.1097/JTO.0b013e31829f6b03

O’Brien K, Comber H, Sharp L. Completeness of case ascertainment at the Irish National Cancer Registry. Ir J Med Sci. Published online August 17, 2013. doi:10.1007/s11845-013-0993-z

Spillane S, Bennett K, Sharp L, Barron TI. A cohort study of metformin exposure and survival in patients with stage I-III colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2013;22(8):1364-1373. doi:10.1158/1055-9965.EPI-13-0347

de Camargo Cancela M, Comber H, Sharp L. Hospital and surgeon caseload are associated with risk of re-operation following breast-conserving surgery. Breast Cancer Res Treat. 2013;140(3):535-544. doi:10.1007/s10549-013-2652-5

Arnold M, Holterhues C, Hollestein LM, et al. Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. Journal of the European Academy of Dermatology and Venereology. 2013;28(9):1170-1178. doi:10.1111/jdv.12236

White C, Keegan H, Pilkington L, et al. Evaluation of the clinical performance of the cobas® 4800 HPV test in a colposcopy referred population. J Clin Microbiol. 2013;51(10):3415-3417. doi:10.1128/JCM.01949-13

de Camargo Cancela M, Comber H, Sharp L. Age remains the major predictor of curative treatment non-receipt for localised prostate cancer: a population-based study. Br J Cancer. 2013;109(1):272-279. doi:10.1038/bjc.2013.268

Kelly M, Sharp L, Dwane F, Kelleher T, Drummond FJ, Comber H. Factors predicting hospital length-of-stay after radical prostatectomy: a population-based study. BMC Health Serv Res. 2013;13(1):244. doi:10.1186/1472-6963-13-244

Flahavan EM, Sharp L, Bennett K, Barron TI. A cohort study of digoxin exposure and mortality in men with prostate cancer. BJU Int. Published online June 13, 2013. doi:10.1111/bju.12287

Skally M, Hanly P, Sharp L. Cost effectiveness of fecal DNA screening for colorectal cancer: a systematic review and quality appraisal of the literature. Appl Health Econ Health Policy. 2013;11(3):181-192. doi:10.1007/s40258-013-0010-8

Hanly P, Céilleachair AO, Skally M, et al. Time costs associated with informal care for colorectal cancer: an investigation of the impact of alternative valuation methods. Appl Health Econ Health Policy. 2013;11(3):193-203. doi:10.1007/s40258-013-0013-5

Hanly P, Céilleachair AO, Skally M, et al. How much does it cost to care for survivors of colorectal cancer? Caregiver’s time, travel and out-of-pocket costs. Support Care Cancer. Published online May 7, 2013. doi:10.1007/s00520-013-1834-3

Sharp L, Carsin AE, Timmons A. Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psychooncology. 2013;22(4):745-755. doi:10.1002/pon.3055